- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
11 result(s) found for: Dry water.
Displaying page 1 of 1.
EudraCT Number: 2006-007024-34 | Sponsor Protocol Number: Stom2009 | Start Date*: 2009-12-28 | ||||||||||||||||
Sponsor Name:General Teaching Hospital | ||||||||||||||||||
Full Title: Treatment of alveolar osteitis using ozonated water | ||||||||||||||||||
Medical condition: Complication after tooth extraction - alveolar osteitis (dry socket). There is no causal treatment of alveolar osteitis. That’s why symptomatic therapy is used. Disinfectants are the most important... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016572-78 | Sponsor Protocol Number: DEBE-01 | Start Date*: 2010-04-27 |
Sponsor Name:Dermal Laboratories Ltd | ||
Full Title: Arm immersion test to compare the skin effects of routine bathing with and without the use of an emollient bath additive. | ||
Medical condition: Eczema sufferers with dry skin. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-000552-27 | Sponsor Protocol Number: ACO2008-CT-01 | Start Date*: 2008-06-11 |
Sponsor Name:ACO HUD NORDIC AB | ||
Full Title: Effect of moisturizing creams on skin barrier function and prevention of Malassezia recurrence in patients with atopic eczema | ||
Medical condition: Dry skin barrier disorders such as atopic eczema and ichtyosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004095-37 | Sponsor Protocol Number: CQAB149A2222 | Start Date*: 2005-02-25 |
Sponsor Name:Novartis Pharma Services | ||
Full Title: An exploratory, multi-center, randomized, open-label, single dose, crossover study to assess the safety and tolerability of 200µg of QAB149, delivered via a MDDPI, with or without the co-administra... | ||
Medical condition: 1) Stable persistent asthma 2) COPD | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) BE (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011418-68 | Sponsor Protocol Number: CSO302L | Start Date*: 2009-10-14 | |||||||||||
Sponsor Name:GlaxoSmithKline Consumer Healthcare GmbH & Co. KG | |||||||||||||
Full Title: Pilotstudie zur Anwendung eines pflanzlichen Kombinationspräparats bei Frauen mit Reizblase ("Overactive Bladder"-Syndrom). (Translation: Pilot-Study with a herbal combination in women suffering f... | |||||||||||||
Medical condition: Frequent micturition and urinary urgency, as common in patients suffering from overactive bladder syndrome. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001903-17 | Sponsor Protocol Number: HMos-012020 | Start Date*: 2020-06-10 |
Sponsor Name:HOSPITAL UNIVERISTARIO DE MOSTOLES | ||
Full Title: A randomized clinical trial (IIIb) of eficacy of a single dose of Tocilizumab or a combination of Tocilizumab plus Vitamin D (single i.m. dose) for the treatment of the COVID-19 hyperimmune complic... | ||
Medical condition: COVID INFECTION IS A MILD FLU LIKE CONDITION WITH MILD FEVER, DRY COUGH, WIDESPREAD TENDERNESS AND OLFACTORY DISFUNCTION FOLLOWED BY A SERIOUS SITUATION IN SOME 20% OF PATIENTS WITH OVERT FEVER, MA... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000615-25 | Sponsor Protocol Number: C-07-13 | Start Date*: 2018-04-05 | |||||||||||
Sponsor Name:Alcon Research Ltd | |||||||||||||
Full Title: Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Externa | |||||||||||||
Medical condition: Acute Otitis Externa | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018686-36 | Sponsor Protocol Number: AX14P1.02 | Start Date*: Information not available in EudraCT |
Sponsor Name:Madaus GmbH | ||
Full Title: Agio-Prep 3g versus Agio-Prep 6g versus Moviprep® - a prospective, randomised, controlled evaluation of bowel cleansing for colonoscopy | ||
Medical condition: Bowel Preparation for Colonoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005075-10 | Sponsor Protocol Number: CL08002 | Start Date*: 2008-10-01 |
Sponsor Name:BioCis Pharma Oy | ||
Full Title: Double-blind, vehicle-controlled, two-phase, single centre Phase I/IIa study with topical twice daily doses of 5% cis-urocanic acid to investigate pharmacokinetics, safety, tolerability and efficac... | ||
Medical condition: Chronic mild to moderate atopic dermatitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003001-26 | Sponsor Protocol Number: 2009 | Start Date*: 2013-12-23 | |||||||||||
Sponsor Name:University of Bristol | |||||||||||||
Full Title: Choice Of Moisturiser in Eczema Treatment (COMET): A feasibility study of pragmatic, single blind, randomised clinical trial to compare the clinical and cost effectiveness of leave-on emollients in... | |||||||||||||
Medical condition: Eczema | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000917-38 | Sponsor Protocol Number: CBPR277X2101 | Start Date*: 2011-09-14 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: A first–in-human study to evaluate safety and tolerability of repeated topical administrations of BPR277 ointment in healthy volunteers, and safety, tolerability, and preliminary efficacy of multip... | ||||||||||||||||||
Medical condition: Part 2: Atopic Dermatitis (AD) Part 3: Netherton Syndrome (NS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
